A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced esophageal carcinoma

被引:0
|
作者
Chatterjee, A.
Biswas, J.
Bhattacharya, S.
Chatterjee, A. K.
Chakraborty, A.
Bhakta, R. S.
机构
[1] Crit Canc Management Res Ctr & Clin, Kolkata, India
[2] Chittaranjan Natl Canc Inst, Kolkata, India
[3] RG Kar Med Coll & Hosp, Kolkata, India
关键词
D O I
10.1200/jco.2011.29.15_suppl.e13044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13044
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced esophageal carcinoma.
    Chatterjee, Aradeep
    Bhattacharya, Sudin
    Chakraborty, Amitava
    Bhakta, Radhe S.
    Chatterjee, Ashim Kumar
    Biswas, Jaydip
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [2] A phase II single-arm clinical trial involving and alternative cancer treatment psorinum therapy in patients with advanced non-small cell lung cancer
    Chatterjee, A.
    Biswas, J.
    Chatterjee, A. K.
    Bhattacharya, S.
    Mukhopadhyay, B. P.
    Chakraborty, A.
    Das, S.
    Bhakta, R. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable metastatic colorectal carcinoma
    Chatterjee, Aradeep
    Bhattacharya, Sudin
    Chatterjee, Ashim Kumar
    Chakraborty, Amitava
    Biswas, Jaydip
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [4] A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with unresectable metastatic colorectal carcinoma.
    Chatterjee, Aradeep
    Chakraborty, Amitava
    Bhattacharya, Sudin
    Bhakta, Radhe S.
    Chatterjee, Ashim Kumar
    Biswas, Jaydip
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with metastatic renal cell carcinoma.
    Chafterjee, Aradeep
    Chakrahorty, Amitava
    Chafterjee, Ashim Kumar
    Bhattacharya, Sudin
    Bhakta, Redhe S.
    Biswas, Jaydip
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] A phase II, single arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with metastatic bladder cancer.
    Chatterjee, Aradeep
    Bhattacharya, Sudin
    Chatterjee, Ashim Kumar
    Chakraborty, Amitava
    Bhakta, Radhe S.
    Biswas, Jaydip
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Psorinum Therapy in Treating Patients With Advanced Non-small Cell Lung Carcinoma (NSCLC): A Phase-II Single Arm Clinical Trial
    Chatterjee, A.
    Biswas, J.
    Bhattacharya, S.
    Chakraborty, A.
    Mukherjee, R.
    Bhakta, R.
    Das, S.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S532 - S532
  • [8] Camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II trial
    Gong, Lei
    Yang, Yueyang
    Zhang, Hongdian
    Qiao, Yufeng
    Wang, Haitong
    Ren, Peng
    Tang, Peng
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
    Liu, Jun
    Yang, Yang
    Liu, Zhichao
    Fu, Xiaolong
    Cai, Xiaoyue
    Li, Hongxuan
    Zhu, Li
    Shen, Yan
    Zhang, Hong
    Sun, Yifeng
    Chen, Hezhong
    Yu, Bentong
    Zhang, Renquan
    Shao, Jinchen
    Zhang, Ming
    Li, Zhigang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [10] Optimization of sinoporphyrin sodium (DVDMS)-mediated photodynamic therapy (PDT) in patients (pts) with advanced esophageal cancer (EC): A multicentre phase II single-arm clinical trial
    Zhou, Jun
    Lu, Zhihao
    Yuan, Jiajia
    Cao, Yanshuo
    Gao, Shegan
    Shu, Yongqian
    Chen, Hao
    Fan, Huizhen
    Zhang, Hao
    Dong, Caihong
    Shan, Tanyou
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)